On the COVID-19 vaccines, well, you have to hand it to him.
intellectual property
Posted inAmerica and the World
The Enduring Corporate Entrenchment in China
Contrary to Thomas Friedman, Wall Street still makes a killing from China at the expense of workers.
Posted inTAP
Connecting National Security to Economic Security
Today on TAP: President Biden toughens America’s stance toward China’s designs on U.S. technologies.
Posted inMoney, Politics, and Power
Trump’s Patent Director Pressured Judges to Rule in His Law Firm’s Favor
Andrei Iancu’s policy decisions greatly benefited his business interests.
Posted inHealth and Social Policy
Drug Pricing Reforms Hinge on the Executive Branch
With Congress stuck, the administration holds the key to whether Americans will see meaningful reductions in prescription drug costs. So far, though, they’ve punted.
Posted inCoronavirus
WTO Fails to Promote COVID Vaccines
Today on TAP: And the U.S., despite Biden’s commitment to a waiver of drug company patent rights, sides with Pharma.
Posted inCoronavirus
Saving Lives Globally vs. Defending Pharma Profits
The U.S. position at a key WTO meeting on intellectual-property waivers for COVID vaccines will reveal which side Joe Biden is on.
Posted inEconomic Policy
Biden’s Successor to TPP Is a Boon for Big Tech
The Indo-Pacific Economic Framework seeks to prohibit forcing tech companies to share source code or store data locally.
Posted inHealth and Social Policy
Where’s the Congressional Champion on Pharma Patent Abuses?
Drug companies are using intellectual-property laws to price-gouge the public, and even Republicans don’t like it.
Posted inCoronavirus
U.S., EU Back Pharma in Denying Access to Lifesaving COVID Products
A compromise effort to waive intellectual-property rights for vaccines, treatments, and tests will do little to expand supply, experts believe.